Cigna Corporation is a global health service company that provides a comprehensive range of health insurance products and services. The company operates across various sectors, including medical, dental, disability, life, and accident insurance, offering coverage to individuals and families, as well as employer-sponsored group plans. Additionally, Cigna delivers integrated health services, such as pharmacy management, behavioral health support, and wellness programs, focusing on improving health outcomes and enhancing the overall well-being of its members. Through its innovative approaches, Cigna aims to create a seamless healthcare experience while addressing the diverse needs of its customers. Read More
San Diego, CA - September 8, 2025 - Harmony Grove Recovery, a premier provider of luxury addiction and mental health treatment, is proud to announce that it now accepts most major health insurance plans for its comprehensive addiction services in San Diego. With coverage for insurers including Cigna, Aetna, GEHA, Tricare, Blue Shield, and many more, the center is broadening access to high-quality, evidence-based care across the region.
Harmony Grove Recovery, a leading addiction treatment center serving the San Diego area, today announced expanded insurance coverage partnerships and enhanced accessibility initiatives designed to make drug and alcohol addiction treatment available to more individuals and families in need.
Beneficiaries impacted by these changes have until December 31, 2025, to select and enroll in new coverage for the upcoming year. While losing a current plan may feel overwhelming, East Coast Health Advisors emphasizes that seniors will not be left without options. A variety of replacement Medicare Advantage and Supplement plans are available, and each client can find a tailored solution that continues to provide comprehensive benefits and peace of mind.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group’s (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratings) is stable. (Please see below for a detailed list of the Long-Term IRs.)
San Diego, CA - September 3, 2025 - Harmony Grove Recovery, a premier provider of luxury addiction and mental health treatment, is proud to announce that it now accepts most major health insurance plans for its comprehensive addiction services in San Diego. With coverage for insurers including Cigna, Aetna, GEHA, Tricare, Blue Shield, and many more, the center is broadening access to high-quality, evidence-based care across the region.
Abbott Laboratories currently trades at $131.61 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 8.8% gain during that period.
The current financial market is witnessing a stark divergence in sector performance, painting a complex picture for investors and the broader economy. While the technology sector, particularly its AI-driven segments, continues its meteoric rise, alongside robust showings from Utilities and Financials, other traditionally stable sectors like Healthcare, Energy, and Industrials
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers.
Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to the momentum in UnitedHealth shares.
Health insurance company Cigna (NYSE:CI) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per share was 0.6% above analysts’ consensus estimates.
Cigna’s second quarter results were met with a significant negative market reaction, reflecting investor concerns despite revenue and adjusted earnings per share both coming in ahead of Wall Street expectations. Management attributed the quarter’s results to continued momentum in its Evernorth services platform and the resilience of its U.S. employer business. However, persistent elevated medical costs, especially in the commercial and individual exchange segments, remained a notable challenge. CEO David Cordani described the company’s performance as “differentiated,” but acknowledged industry disruption and the necessity of ongoing portfolio adjustments. Management also highlighted product innovation, such as new GLP-1 benefit options and AI-powered virtual assistance, as key contributors to maintaining customer engagement and operational execution.
